MBX BIOSCIENCES INC (MBX) Stock Analyst Ratings
NASDAQ:MBX - Nasdaq - US55287L1017 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to MBX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 38.25. This target is 178.18% above the current price.
MBX was analyzed by 9 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about MBX.
In the previous month the buy percentage consensus was at a similar level.
MBX was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-16 | Oppenheimer | Initiate | Outperform |
| 2025-04-10 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-04-10 | JMP Securities | Initiate | Market Outperform |
| 2024-10-08 | Guggenheim | Initiate | Buy |
| 2024-10-08 | Stifel | Initiate | Buy |
| 2024-10-08 | JP Morgan | Initiate | Overweight |
| 2024-10-08 | Jefferies | Initiate | Buy |